Overview

Update
Investments
164 Investments in 86 Companies
Exits
16 IPOs & 22 Acquisitions
Founders:
,
Headquarters:
Cambridge, Massachusetts
Funds Raised:
$1.4B
Categories:
Pharmaceutical, Medical Device, Health Care, Biotechnology
Description:
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs(TM)
Website:
http://www.flagshipventures.com
Social:

Investor Details

Update
Founded:
2000
Type:
Venture Capital that does Early Stage Venture, Later Stage Venture, Private Equity, and Debt Financing Investments
Sectors:
Biotechnology, Health Care, Software
Regions:
United States

Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs(TM) which invents and launches transformative companies, and Venture Capital, which finances and realizes innovative, early-stage companies. Founded in 2000, and based in Cambridge, Massachusetts, Flagship Ventures manages over $900 million in capital. The Flagship team innovates and invests in three principal business sectors: therapeutics, health technologies and sustainability/clean technology. Past successful Flagship portfolio ventures include: Adnexus (acquired by Bristol-Myers Squibb), Accuri Cytometers (acquired by Becton, Dickinson), Morphotek (acquired by Eisai), Color Kinetics (acquired by Philips), AVEO (NASDAQ: AVEO) and BG Medicine (NASDAQ: BGMD). Recent notable portfolio ventures include: Joule Unlimited, Agios, Affinnova, AeroDesigns and Novomer. For more information, please visit www.flagshipventures.com.

Acquisitions (1)

Update
DateInvested InRoundPartner(s)
Jul, 2016$100M / Series C
May, 2016$51.2M / Private Equity
Feb, 2016$48.5M / Series B (Lead)
Jan, 2016$61M / Series B (Lead)
Dec, 2015$25M / Series A (Lead)
Nov, 2015$31M / Series A
Nov, 2015$35M / Venture (Lead)
Oct, 2015$32M / Private Equity (Lead)
Sep, 2015$38M / Series E
Aug, 2015$120M / Series B
May, 2015$39M / Series C, , , , and
May, 2015$217M / Series A
Mar, 2015undisclosed amount / Venture
Jan, 2015$21M / Series B
Dec, 2014$48M / Series C (Lead)
Nov, 2014$7.5M / Series A (Lead)
Oct, 2014$53M / Series B
Oct, 2014$30M / Series B
Sep, 2014$20M / Series F
Aug, 2014$16M / Series B
May, 2014undisclosed amount / Series B
Dec, 2013$21M / Series B
Dec, 2013undisclosed amount / Series B (Lead)
Dec, 2013$8.1M / Series A
Nov, 2013$43M / Series A (Lead)
Nov, 2013$110M / Private Equity
Oct, 2013$10.8M / Series A (Lead)
Apr, 2013$30M / Series A (Lead)
Mar, 2013$40M / Series E
Mar, 2013$13.5M / Private Equity
Mar, 2013$43M / Series D
Dec, 2012$40M / Venture (Lead)
Nov, 2012undisclosed amount / Series A (Lead)
Nov, 2012$18.5M / Series C
Nov, 2012$8.62M / Series B
Nov, 2012$26.1M / Series A
Sep, 2012$10M / Series A (Lead)
Jun, 2012$10M / Series A (Lead)
May, 2012$20M / Series A
Mar, 2012$30M / Venture

Current Team (27)

Update

Board Members and Advisors (2)

Update

Funds (5)

Update
AnnouncedNameAmount
Mar 26, 2015Flagship Ventures Fund V$587M
Jan 1, 2007Flagship Ventures Fund III$235M
Jan 1, 2004Flagship Ventures Fund II$152M
Jun 1, 2000Flagship Ventures Fund I$155M
Unknown DateFlagship Ventures Fund IV$270M

Offices/Locations (1)

Update
  • Headquarters

    One Memorial Drive

    7th Floor

    Cambridge, Massachusetts 02142

    United States

Images (1)

Update

Add Competitors

Add Memberships

Add Videos